Abstract:BACKGROUND:Mouse double minute 2 (MDM2) and vascular endothelial growth factor (VEGF) are important molecules involved in tumor progression. We researched potential inhibitors that simultaneously target MDM2 and VEGF. In our recent study involving the performance of high-throughput screening with a fluorescence polarization assay, gossypol was identified as one of the top hits that inhibit protein-RNA binding activity. Because MDM2 is an RNA-binding protein and its targets include VEGF mRNA, we investigated whether gossypol has an inhibitory effect on MDM2-VEGF.METHODS:UV cross-linking and RNA binding assay, isothermal titration calorimetry assay, and ubiquitination assay were performed to determine mechanisms by which gossypol functions as a dual inhibitor of MDM2 and VEGF. The effect of gossypol on MDM2 and VEGF expression, cancer cell apoptosis, tumor growth and VEGF-mediated angiogenesis were studied in vitro and in vivo in different human breast cancer models with a different p53 status.RESULTS:We observed that gossypol inhibited expression of both MDM2 and VEGF in human breast cancer cells with either wild-type or mutant p53. A nechanistic study further demonstrated that, through disrupting the interaction between MDM2 protein and VEGF mRNA, gossypol induced MDM2 self-ubiquitination and decreased VEGF translation simultaneously, which resulted in both apoptosis and anti-angiogenesis effects. In vitro, regardless of p53 status, gossypol induced cancer cell apoptosis. In nude mouse xenograft in vivo models, gossypol suppressed tumor growth and VEGF-mediated angiogenesis.CONCLUSION:Gossypol has anti-cancer effects by dual-targeting MDM2 and VEGF in human breast cancer. Our study reveals a novel mechanism by which gossypol functions as an anticancer agent. We believe that MDM2-VEGF targeting represents a novel strategy for improving cancer outcome.

Gossypol Inhibits Metastasis of Lung Cell Carcinoma by Reversing Epithelial to Mesenchymal Transition and Suppressing Proteases Activity

Gossypol Has Anti-Cancer Effects by Dual Targeting Mdm2 and Vegf in Human Breast Cancer

Molecular Mechanism of Gossypol-Induced Cell Growth Inhibition and Cell Death of HT-29 Human Colon Carcinoma Cells.

Suppression of LPS-induced Inflammatory Responses by Gossypol in RAW 264.7 Cells and Mouse Models.

Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity As an Inhibitor of Antiapoptotic Proteins.

(-)-Gossypol Suppresses the Growth of Human Prostate Cancer Xenografts Via Modulating Vegf Signaling-Mediated Angiogenesis

Gossypol overcomes EGFR-TKIs resistance in non-small cell lung cancer cells by targeting YAP/TAZ and EGFRL858R/T790M

Gossypol induces apoptosis of human pancreatic cancer cells via CHOP/endoplasmic reticulum stress signaling pathway

Natural Product (-)-gossypol Inhibits Colon Cancer Cell Growth by Targeting Rna-Binding Protein Musashi-1

The Immunosuppressive Effect of Gossypol in Mice is Mediated by Inhibition of Lymphocyte Proliferation and by Induction of Cell Apoptosis

Gomisin A Suppresses Colorectal Lung Metastasis by Inducing AMPK/p38-Mediated Apoptosis and Decreasing Metastatic Abilities of Colorectal Cancer Cells

Dual Effects of Gossypol on Human Hepatocellular Carcinoma Via Endoplasmic Reticulum Stress and Autophagy.

Gleditsia Saponin C Induces A549 Cell Apoptosis via Caspase-Dependent Cascade and Suppresses Tumor Growth on Xenografts Tumor Animal Model

In Vitro Effects of the BH3 Mimetic, (−)-Gossypol, on Head and Neck Squamous Cell Carcinoma Cells

Bioinformatics Analysis Of The Signaling Pathways And Genes Of Gossypol Induce Death Of Nasopharyngeal Carcinoma Cells

Natural Product Gossypol and Its Derivatives in Precision Cancer Medicine

The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer.

Inhibition Of Proliferation Of Prostate Cancer Cell Line, Pc-3, In Vitro And In Vivo Using (-)-Gossypol

Effects of gossypol on the in vitro proliferation and apoptosis of murine lymphocytes

Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma

Involvement of Bcl-2, Src, and ERα in Gossypol-Mediated Growth Inhibition and Apoptosis in Human Uterine Leiomyoma and Myometrial Cells